China's bet on homegrown mRNA vaccines holds back nation
Companies, agencies, institutions, etc
AP
Fosun Pharma
mRNA
Pfizer and BioNTech
Yale University’s School of Public Health
Pfizer-BioNTech
Moderna
COVID-19
The Associated Press
The Communist Party
Global Times
National Health Commission
the National Medical Products Administration
Abogen Biosciences
Walvax
the Academy of Military Medical Sciences
the Indian Institute of Science Education and Research
BioInno Bioscience
this report.___The Associated Press Health and Science Department
the Howard Hughes Medical Institute’s Department of Science Education
People
Xi Chen
Bo Ying
Vineeta Bal
Scott Wheelwright
Dake Kang
Groups
Chinese
mRNA
Western
COVID-19
American
Physical locations
No matching tags
Places
No matching tags
Locations
TAIPEI
Taiwan
China
Hong Kong
Macao
Shanghai
Fosun
Pune
India
New Delhi
Beijing
Events
COVID-19.As
Summary
TAIPEI, Taiwan (AP) — China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection against the worst outcomes from COVID-19.As early as the spring of 2020 a Chinese pharmaceutical company, Fosun Pharma, reached an agreement to distribute — and eventually manufacture — the mRNA vaccine made by Pfizer and BioNTech. In the meantime, Chen, the Yale health policy expert, said the Chinese government should better protect its elderly population by both approving the Pfizer vaccine and encouraging booster shots.
As said here by HUIZHONG WU and ANIRUDDHA GHOSAL